NCT02388048 2025-01-29
Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2 Completed
Clinical Trials
6 trialsNCT06335277 2024-03-28
Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology
European Institute of Oncology
Recruiting
NCT01240525 2019-02-12
ProT4
University College, London
Phase 2 Unknown
NCT01600053 2016-12-15
Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
University of California, San Diego
Phase 2 Terminated
NCT00280241 2016-02-04
Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
University of Pittsburgh
Phase 2 Completed
NCT01373983 2014-12-30
ZicBol
University Hospital, Linkoeping
Phase 4 Completed